Form 4: Procter & Gamble Director Joseph Jimenez Acquires Shares Through Stock Award

Sentiment:

SEC Form 4 Filing


Director Joseph Jimenez of Procter & Gamble acquired 276 shares of common stock through a restricted stock unit award.

Summary

  • Joseph Jimenez, a director at Procter & Gamble, acquired 276 shares of common stock on December 10, 2024.
  • The acquisition was made through a restricted stock unit award under the company's 2019 Stock and Incentive Compensation Plan.
  • The price per share for the acquisition was $0, indicating it was a grant rather than a purchase.
  • Following the transaction, Jimenez's total direct holdings in Procter & Gamble common stock increased to 32,858.8078 shares, which includes dividend equivalents in the form of restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally positive as it shows alignment of interests between management and shareholders. There are no negative implications.

Positives

  • The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future performance.
  • The use of restricted stock units aligns the director's interests with those of the shareholders.

Industry Context

This is a routine filing related to insider transactions, which is common for publicly traded companies like Procter & Gamble. It reflects the company's compensation practices and is not unusual in the consumer goods industry.

Comparison to Industry Standards

  • Stock-based compensation is a common practice among large, publicly traded companies like Procter & Gamble, including competitors such as Unilever, Colgate-Palmolive, and Kimberly-Clark.
  • These companies often use restricted stock units as part of their executive compensation packages to align management's interests with those of shareholders.
  • The number of shares granted and the specific terms of the grant are generally consistent with industry standards for director compensation.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.
  • The transaction has no direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
12/10/2024Date of the stock acquisition by Joseph Jimenez.
12/11/2024Date the form was signed by the attorney-in-fact.

Keywords

Procter & Gamble, stock acquisition, restricted stock units, director, Joseph Jimenez, insider trading, equity compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.